Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

127120:KS

17,450 KRW 650 3.87%

As of 02:22:34 ET on 03/31/2015.

Snapshot for DNA Link Inc (127120)

Open: 17,000 Day's Range: 16,050 - 17,550 Volume: 251,669
Previous Close: 16,800 52wk Range: 9,540 - 22,400 1-Yr Rtn: +69.42%

Stock Chart for 127120

No chart data available.
  • 127120:KS 17,400
  • 1D
  • 1M
  • 1Y
16,800
Interactive 127120 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 127120

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. KOSPI -
Earnings Per Share (KRW) (ttm) -1,418.0000
Est. EPS (KRW) (12/2015) -
Est. PEG Ratio -
Market Cap (M KRW) 98,652.53
Shares Outstanding (M) 5.65
30 Day Average Volume 183,100
Price/Book (mrq) 8.0968
Price/Sale (ttm) 13.3116
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 127120

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 127120

DNA Link Inc. is a biotechnology company specializing in genomic research technology for rapid analysis of whole genomes. The Company also provides personalized genomic service which analyze individual's genomic sequence to identify his or her susceptibility to genetic diseases and calculate their risk factors.

Lee Jong-EunCEO/Rep DirectorKim Hyung-BaeExecutive Director
More Company Profile & Key Executives for 127120

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil